Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Feb 28, 2025 | (FY)Feb 29, 2024 | (FY)Feb 28, 2023 | (FY)Feb 28, 2022 | (FY)Feb 28, 2021 | (FY)Feb 28, 2019 | (FY)Feb 28, 2018 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 6.75%20.52M | 1.29%19.22M | 5.98%18.98M | 3.27%17.91M | 17.34M | 8.44%16.23M | 14.97M |
| Cost of revenue | 3.82%11.3M | 4.67%10.88M | 9.83%10.4M | 1.00%9.47M | 9.37M | 3.42%8.38M | 8.11M |
| Gross profit | 10.56%9.22M | -2.80%8.34M | 1.66%8.58M | 5.93%8.44M | 7.97M | 14.36%7.85M | 6.86M |
| Operating expense | 13.62%3.37M | -2.43%2.97M | 9.41%3.04M | -14.70%2.78M | 3.26M | 17.53%2.9M | 2.46M |
| Staff costs | ---- | ---- | ---- | ---- | ---- | 19.58%1.66M | --1.39M |
| Selling and administrative expenses | 13.51%3.37M | -2.33%2.97M | 9.41%3.04M | -16.39%2.78M | --3.32M | 13.70%1.08M | --949K |
| -General and administrative expense | 13.51%3.37M | -2.33%2.97M | 9.41%3.04M | -16.39%2.78M | --3.32M | 13.70%1.08M | --949K |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | 23.81%156K | --126K |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | 23.81%156K | --126K |
| Other operating expenses | ---- | ---3K | ---- | ---- | ---65.84K | ---- | ---- |
| Total other operating income | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
| Operating profit | 8.87%5.85M | -3.01%5.38M | -2.15%5.54M | 20.20%5.66M | 4.71M | 12.58%4.95M | 4.4M |
| Net non-operating interest income (expenses) | -1.09%-279K | -0.08%-276K | 0.58%-275.79K | -37.87%-277.39K | -201.2K | -2,488.13%-39.03K | -1.51K |
| Non-operating interest expense | 1.09%279K | 0.08%276K | -0.58%275.79K | 37.87%277.39K | --201.2K | 2,488.13%39.03K | --1.51K |
| Net investment income | 234.00%167K | 50K | |||||
| Gain(Loss) on financial instruments designated as cash flow hedges | |||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -86.49%45K | 333K | |||||
| Income from associates and other participating interests | |||||||
| Special income (charges) | |||||||
| Other non-operating income (expenses) | 38.43%4.95M | 208.76%3.57M | -24.43%1.16M | -3.52%1.53M | 1.59M | 100.00%70K | 35K |
| Income before tax | 21.30%10.52M | 35.01%8.67M | -7.15%6.42M | 13.44%6.92M | 6.1M | 7.88%5.19M | 4.81M |
| Income tax | -4.21%1.34M | -9.05%1.4M | 4.31%1.54M | 26.08%1.48M | 1.17M | 18.94%1.19M | 1M |
| Net income | 26.21%9.18M | 48.92%7.27M | -10.25%4.88M | 10.44%5.44M | 4.93M | 4.98%4M | 3.81M |
| Net income continuous operations | 26.21%9.18M | 48.92%7.27M | -10.25%4.88M | 10.44%5.44M | --4.93M | 4.98%4M | --3.81M |
| Noncontrolling interests | |||||||
| Net income attributable to the company | 26.21%9.18M | 48.92%7.27M | -10.25%4.88M | 10.44%5.44M | 4.93M | 4.98%4M | 3.81M |
| Preferred stock dividends | |||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 26.21%9.18M | 48.92%7.27M | -10.25%4.88M | 10.44%5.44M | 4.93M | 4.98%4M | 3.81M |
| Gross dividend payment | |||||||
| Basic earnings per share | 26.22%0.0337 | 49.16%0.0267 | -10.50%0.0179 | 10.50%0.02 | 0.0181 | 4.99%0.0147 | 0.014 |
| Diluted earnings per share | 26.22%0.0337 | 49.16%0.0267 | -10.50%0.0179 | 10.50%0.02 | 0.0181 | 4.99%0.0147 | 0.014 |
| Dividend per share | |||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.